J7511 Insurance Policy Changes

08.01.88b, Allogeneic Processed Thymus Tissue-agdc (Rethymic®)

This policy update modifies the medical necessity criteria for Rethymic® (allogeneic processed thymus tissue-agdc), a specialty pharmaceutical product. The billing team must ensure claims for this medication are submitted with updated medical necessity documentation requirements to avoid denials. Specific criteria details are not provided in the source material, so the full policy text must be reviewed and implemented.